SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-20-017935
Filing Date
2020-04-22
Accepted
2020-04-22 16:30:35
Documents
3
Period of Report
2020-06-16
Effectiveness Date
2020-04-22

Document Format Files

Seq Description Document Type Size
1 DEF 14A atra-def14a_20200616.htm DEF 14A 885452
2 GRAPHIC gnvcqzdiwpzq000001.jpg GRAPHIC 62995
3 GRAPHIC gnvcqzdiwpzq000002.jpg GRAPHIC 56254
  Complete submission text file 0001564590-20-017935.txt   1051059
Mailing Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080 650-278-8930
Atara Biotherapeutics, Inc. (Filer) CIK: 0001604464 (see all company filings)

IRS No.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36548 | Film No.: 20808224
SIC: 2836 Biological Products, (No Diagnostic Substances)